Vanguard Group Inc Kura Oncology, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,348,325 shares of KURA stock, worth $33.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,348,325
Previous 4,948,235 8.09%
Holding current value
$33.2 Million
Previous $32.7 Million 5.51%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$5.55 - $6.92 $2.22 Million - $2.77 Million
400,090 Added 8.09%
5,348,325 $30.9 Million
Q1 2025

May 09, 2025
BUY
$6.6 - $9.05 $853,624 - $1.17 Million
129,337 Added 2.68%
4,948,235 $32.7 Million
Q4 2024

Feb 11, 2025
BUY
$8.51 - $19.21 $5.24 Million - $11.8 Million
615,211 Added 14.64%
4,818,898 $42 Million
Q3 2024

Nov 13, 2024
BUY
$18.57 - $23.23 $3.03 Million - $3.79 Million
163,231 Added 4.04%
4,203,687 $82.1 Million
Q2 2024

Aug 13, 2024
SELL
$17.53 - $22.98 $446,085 - $584,772
-25,447 Reduced 0.63%
4,040,456 $83.2 Million
Q1 2024

May 10, 2024
BUY
$13.42 - $23.53 $378,605 - $663,828
28,212 Added 0.7%
4,065,903 $86.7 Million
Q4 2023

Feb 14, 2024
BUY
$7.58 - $14.38 $858,381 - $1.63 Million
113,243 Added 2.89%
4,037,691 $58.1 Million
Q3 2023

Nov 14, 2023
BUY
$8.44 - $11.86 $2.32 Million - $3.26 Million
275,173 Added 7.54%
3,924,448 $35.8 Million
Q2 2023

Aug 14, 2023
BUY
$9.62 - $13.99 $1.6 Million - $2.32 Million
166,055 Added 4.77%
3,649,275 $38.6 Million
Q1 2023

May 15, 2023
BUY
$10.71 - $14.6 $835,926 - $1.14 Million
78,051 Added 2.29%
3,483,220 $42.6 Million
Q4 2022

Feb 10, 2023
BUY
$11.23 - $16.9 $1.29 Million - $1.94 Million
114,968 Added 3.49%
3,405,169 $42.3 Million
Q3 2022

Nov 14, 2022
SELL
$12.01 - $19.45 $529,220 - $857,064
-44,065 Reduced 1.32%
3,290,201 $44.9 Million
Q2 2022

Aug 12, 2022
BUY
$10.71 - $18.33 $41,983 - $71,853
3,920 Added 0.12%
3,334,266 $61.1 Million
Q1 2022

May 13, 2022
BUY
$11.78 - $16.98 $667,195 - $961,713
56,638 Added 1.73%
3,330,346 $53.6 Million
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $112,949 - $180,885
9,243 Added 0.28%
3,273,708 $45.8 Million
Q3 2021

Nov 12, 2021
SELL
$15.42 - $21.72 $218,732 - $308,098
-14,185 Reduced 0.43%
3,264,465 $61.1 Million
Q2 2021

Aug 13, 2021
BUY
$20.85 - $29.88 $68.4 Million - $98 Million
3,278,650 New
3,278,650 $68.4 Million

Others Institutions Holding KURA

# of Institutions
189
Shares Held
79.5M
Call Options Held
53.6K
Put Options Held
42.8K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $415M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email